Search Within

Neuroblastoma Service

  1. "Biostatistics Service"
Formats
  1. Journal Article (56)
  2. Meeting Abstract (26)
  3. Conference Paper (2)
Groups
  1. Biostatistics Service (84)
  2. Epidemiology and Biostatistics (84)
  3. Pediatrics, Department of (84)
  4. Tow Center for Developmental Oncology (TCDO) (72)
  5. GSK Faculty (71)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (67)

More Groups

People
  1. Nai-Kong Cheung (66)
  2. Brian Kushner (46)
  3. Shakeel Modak (37)
  4. Kim Kramer (27)
  5. Audrey Mauguen (26)
  6. Irene Cheung (26)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (4)
  4. 2022 (5)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Pediatric Blood and Cancer (15)
  3. Cancer Research (6)
  4. Cancer (4)
  5. Clinical Cancer Research (3)
  6. Medical and Pediatric Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Wiley Periodicals, Inc (17)
  3. American Association for Cancer Research (11)
  4. Wiley Blackwell (4)
  5. Wiley Liss (3)
  6. John Wiley & Sons (2)

More Publishers

Results (84)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A single institutional experience using romiplostim to manage treatment related thrombocytopenia in pediatric solid tumor patients
    Meeting Abstract

    Degliuomini, M.; Armstrong, K.; Curry, M.; Mauguen, A.; Modak, S.; Dunkel, I.; Mones, J.; Ortiz, M.
    Blood (2022)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term survival from a phase 1 doseescalation trial using convection-enhanced delivery (CED) of radioimmunotherapeutic (124)I-omburtamab for treatment of diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Tasker, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Dunkel, I. J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Chemotherapy‐induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention
    Journal Article

    Degliuomini, M. D.; Armstrong, K.; Mauguen, A.; Slotkin, E. K.; Roberts, S. S.; Dunkel, I. J.; Clouser, M.; Ortiz, M. V.; Soff, G. A.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Phase I trial of oral yeast-derived β-glucan to enhance anti-GD2 immunotherapy of resistant high-risk neuroblastoma
    Journal Article

    Iglesias Cardenas, F.; Mauguen, A.; Cheung, I. Y.; Kramer, K.; Kushner, B. H.; Ragupathi, G.; Cheung, N. K. V.; Modak, S.
    Cancers (2021)

    Fulltext@MSK | Save
  • Translational strategies for repotrectinib in neuroblastoma
    Journal Article

    O'Donohue, T. J.; Ibáñez, G.; Coutinho, D. F.; Mauguen, A.; Siddiquee, A.; Rosales, N.; Calder, P.; Ndengu, A.; You, D.; Long, M.; more...
    Molecular Cancer Therapeutics (2021)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response in a phase II ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression
    Journal Article

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Feng, Y.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save